Literature DB >> 1862750

Hypotensive action of IgG preparations containing aggregates is suppressed by PAF-receptor antagonist BN 52021 and by gadolinium chloride (an agent blocking Kupffer cell function).

B Jenei1, G Lázár, K Bartha, G A Medgyesi.   

Abstract

The hypotensive side effect of four IgG preparations was studied in a rat model. An unmodified, chromatographically isolated preparation (prepn. C) appeared to induce a transient drop in blood pressure via the kininogen kinin system. A preparation made by ethanol fractionation (prepn. E) and an ethanol-fractionated, modified product (prepn. M) produced an action which does not depend on kininogen activation. No blocking of kininase was required for this effect and it was brought about by prepn. M was devoid of any sizeable prekallikrein activator or kallikrein like proteinase content. The effect was associated by the aggregate fraction of prepn. E, but not with IgG monomers of the same preparation. Animals given these latter types of IgG preparations were refractory to a second dose 24 hours later. The involvement of PAF in the kinin-independent hypotensive action is suggested by the finding that PAF-receptor antagonist BN 52021 prevented the effect and returned the blood pressure close to normality when given during hypotension. A blockade of Kupffer cells brought about by administration of GdCl3 was also found to prevent the effect pointing to the involvement of these type of cells in the reactions.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1862750     DOI: 10.1007/bf01980894

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  20 in total

1.  The reticuloendothelial-blocking effect of rare earth metals in rats.

Authors:  G Lazar
Journal:  J Reticuloendothel Soc       Date:  1973-03

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Antihypertensive activity of an alkyl ether analog of phosphatidylcholine.

Authors:  M L Blank; F Snyder; L W Byers; B Brooks; E E Muirhead
Journal:  Biochem Biophys Res Commun       Date:  1979-10-29       Impact factor: 3.575

4.  Platelet-activating factor (PAF-acether) and macrophages. II. Phagocytosis-associated release of PAF-acether from rat peritoneal macrophages.

Authors:  J M Mencia-Huerta; J Benveniste
Journal:  Cell Immunol       Date:  1981-01-15       Impact factor: 4.868

5.  Hypotensive activity of PAF-acether in rats.

Authors:  C G Caillard; S Mondot; J L Zundel; L Julou
Journal:  Agents Actions       Date:  1982-12

6.  Electron microscopic study of Kupffer-cell phagocytosis blockade induced by gadolinium chloride.

Authors:  E Husztik; G Lázár; A Párducz
Journal:  Br J Exp Pathol       Date:  1980-12

7.  Key role of macrophages in hypotensive side effects of immunoglobulin preparations. Studies in an animal model.

Authors:  W K Bleeker; J Agterberg; G Rigter; N van Rooijen; J C Bakker
Journal:  Clin Exp Immunol       Date:  1989-09       Impact factor: 4.330

8.  Neutropenia induced by platelet-activating factor (PAF-acether) released from neutrophils: the inhibitory effect of prostacyclin (PGI2).

Authors:  G Camussi; C Tetta; G Segoloni; M Chiara Deregibus; F Bussolino
Journal:  Agents Actions       Date:  1981-12

9.  Hypotensive effects of plasma protein fraction. The relation between prekallikrein activator, bradykinin generation, and blood pressure in an animal model.

Authors:  W K Bleeker; R F Van Rosevelt; J G Ufkes; J A Loos; J A Van Mourik; J C Bakker
Journal:  J Lab Clin Med       Date:  1982-10

10.  Inhibition of the vascular actions of IgG aggregates by BN 52021, a highly specific antagonist of paf-acether.

Authors:  M Sánchez-Crespo; S Fernández-Gallardo; M L Nieto; J Baranès; P Braquet
Journal:  Immunopharmacology       Date:  1985-10
View more
  3 in total

1.  Induction of shock after intravenous injection of adenovirus vectors: a critical role for platelet-activating factor.

Authors:  Zhili Xu; Jeffrey S Smith; Jie Tian; Andrew P Byrnes
Journal:  Mol Ther       Date:  2009-12-01       Impact factor: 11.454

2.  Inhibition of anaphylactic shock by gadolinium chloride-induced Kupffer cell blockade.

Authors:  G Lázár; G Lázár; J Kaszaki; J Oláh; I Kiss; E Husztik
Journal:  Agents Actions       Date:  1994-06

3.  Engineered hexavalent Fc proteins with enhanced Fc-gamma receptor avidity provide insights into immune-complex interactions.

Authors:  Tania F Rowley; Shirley J Peters; Mike Aylott; Robert Griffin; Nicola L Davies; Louise J Healy; Rona M Cutler; Alison Eddleston; Thomas L Pither; Joshua M Sopp; Oliver Zaccheo; Gianluca Fossati; Katharine Cain; Andrew M Ventom; Hanna Hailu; Eleanor J Ward; John Sherington; Frank R Brennan; Farnaz Fallah-Arani; David P Humphreys
Journal:  Commun Biol       Date:  2018-09-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.